Publications 2023
Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.
Neuro-oncology practice 10(3), 307 - 314 (2023) [10.1093/nop/npad004]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
Journal of neuro-oncology nn, nn (2023) [10.1007/s11060-023-04319-1]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Nature genetics nn, nn (2023) [10.1038/s41588-023-01315-z]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
Nature genetics nn, nn (2023) [10.1038/s41588-023-01318-w]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
Nature genetics nn, nn (2023) [10.1038/s41588-023-01319-9]
BibTeX |
EndNote:
XML,
Text |
RIS
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Acta neuropathologica 145(6), 829-842 (2023) [10.1007/s00401-023-02575-z]
BibTeX |
EndNote:
XML,
Text |
RIS
Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks.
Frontiers in oncology 13, 1167082 (2023) [10.3389/fonc.2023.1167082]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.
Neuro-Oncology nn, nn (2023) [10.1093/neuonc/noad078]
BibTeX |
EndNote:
XML,
Text |
RIS
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.
Journal of clinical oncology nn, nn (2023) [10.1200/JCO.22.02430]
BibTeX |
EndNote:
XML,
Text |
RIS
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature.
npj precision oncology 7(1), 30 (2023) [10.1038/s41698-023-00372-1]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Genomic characterization of DICER1-associated neoplasms uncovers molecular classes.
Nature Communications 14(1), 1677 (2023) [10.1038/s41467-023-37092-w]
BibTeX |
EndNote:
XML,
Text |
RIS
Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84].
European journal of cancer nn, nn (2023) [10.1016/j.ejca.2023.02.024]
BibTeX |
EndNote:
XML,
Text |
RIS
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Acta neuropathologica nn, nn (2023) [10.1007/s00401-023-02558-0]
BibTeX |
EndNote:
XML,
Text |
RIS
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.
Nature medicine nn, nn (2023) [10.1038/s41591-023-02255-1]
BibTeX |
EndNote:
XML,
Text |
RIS
Genomic ALK alterations in primary and relapsed neuroblastoma.
British journal of cancer nn, nn (2023) [10.1038/s41416-023-02208-y]
BibTeX |
EndNote:
XML,
Text |
RIS
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Acta neuropathologica 145(4), 511-514 (2023) [10.1007/s00401-023-02538-4]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: Pan-cancer analysis of whole genomes
Nature <London> 614, E39 (2023) [10.1038/s41586-022-05598-w]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: Patterns of somatic structural variation in human cancer genomes
Nature <London> 614, E38 (2023) [10.1038/s41586-022-05597-x]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: The repertoire of mutational signatures in human cancer
Nature <London> 614, E41 (2023) [10.1038/s41586-022-05600-5]
BibTeX |
EndNote:
XML,
Text |
RIS
Risk prediction in early childhood SHH medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than two subgroups.
Neuro-Oncology nn, nn (2023) [10.1093/neuonc/noad027]
BibTeX |
EndNote:
XML,
Text |
RIS
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.
Nature cancer 4(2), 276-289 (2023) [10.1038/s43018-022-00509-4]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: Genomic basis for RNA alterations in cancer
Nature <London> 614(7948), p. E37 (2023) [10.1038/s41586-022-05596-y]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Nature <London> 614(7948), p. E40 (2023) [10.1038/s41586-022-05599-9]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: The evolutionary history of 2,658 cancers
Nature <London> 614(7948), p. E42 (2023) [10.1038/s41586-022-05601-4]
BibTeX |
EndNote:
XML,
Text |
RIS
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.
Acta Neuropathologica Communications 11(1), 7 (2023) [10.1186/s40478-023-01504-1]
BibTeX |
EndNote:
XML,
Text |
RIS
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.
European journal of cancer 180, 71 - 84 (2023) [10.1016/j.ejca.2022.11.015]
BibTeX |
EndNote:
XML,
Text |
RIS
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
Acta neuropathologica 145(1), 97-112 (2023) [10.1007/s00401-022-02522-4]
BibTeX |
EndNote:
XML,
Text |
RIS
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Acta neuropathologica 145(1), 49-69 (2023) [10.1007/s00401-022-02516-2]
BibTeX |
EndNote:
XML,
Text |
RIS
Clinical implementation of integrated molecular-morphologic risk prediction for meningioma.
Brain pathology 33(3), e13132 (2023) [10.1111/bpa.13132]
BibTeX |
EndNote:
XML,
Text |
RIS
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein.
Molecular oncology 17(1), 37-58 (2023) [10.1002/1878-0261.13318]
BibTeX |
EndNote:
XML,
Text |
RIS
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.
Neuro-Oncology 25(4), 735-747 (2023) [10.1093/neuonc/noac199]
BibTeX |
EndNote:
XML,
Text |
RIS
The first-in-class ERK inhibitor ulixertinib shows promising activity in MAPK-driven pediatric low-grade glioma models.
Neuro-Oncology 25(3), 566-579 (2023) [10.1093/neuonc/noac183]
BibTeX |
EndNote:
XML,
Text |
RIS